Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE DE PERIAZ : revenue, balance sheet and financial ratios

GRANDE PHARMACIE DE PERIAZ is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ANNECY (74000), this company of category PME shows in 2017 a revenue of 3.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE DE PERIAZ (SIREN 485095830)
Indicator 2024 2017 2016
Revenue N/C 3 311 402 € N/C
Net income 277 582 € 171 824 € 122 122 €
EBITDA N/C 294 658 € N/C
Net margin N/C 5.2% N/C

Revenue and income statement

In 2024, GRANDE PHARMACIE DE PERIAZ generates positive net income of 278 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 122 k€ -> 278 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

277 582 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

25.855%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

63.547%

Solvency indicators evolution
GRANDE PHARMACIE DE PERIAZ

Sector positioning

Debt ratio
25.86 2024
2016
2017
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good -18 pts over 3 years

In 2024, the debt ratio of GRANDE PHARMACIE DE PERIAZ (25.86) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
63.55% 2024
2016
2017
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +13 pts over 3 years

In 2024, the financial autonomy of GRANDE PHARMACIE DE PERIAZ (63.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
4.51 years 2017
2017
Q1: 2.26 years
Med: 5.88 years
Q3: 10.41 years
Good

In 2017, the repayment capacity of GRANDE PHARMACIE DE PERIAZ (4.51) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 146.63. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

146.63

Liquidity indicators evolution
GRANDE PHARMACIE DE PERIAZ

Sector positioning

Liquidity ratio
146.63 2024
2016
2017
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average +9 pts over 3 years

In 2024, the liquidity ratio of GRANDE PHARMACIE DE PERIAZ (146.63) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
12.46x 2017
2017
Q1: 2.81x
Med: 8.18x
Q3: 15.34x
Good

In 2017, the interest coverage of GRANDE PHARMACIE DE PERIAZ (12.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
GRANDE PHARMACIE DE PERIAZ

Positioning of GRANDE PHARMACIE DE PERIAZ in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of GRANDE PHARMACIE DE PERIAZ is estimated at 3 875 249 € (range 2 698 662€ - 5 797 595€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2698k€ 3875k€ 5797k€
3 875 249 € Range: 2 698 662€ - 5 797 595€
NAF 5 année 2024

Valuation method used

Net Income Multiple
277 582 € × 14.0x = 3 875 250 €
Range: 2 698 663€ - 5 797 596€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE DE PERIAZ with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE DE PERIAZ

What is the revenue of GRANDE PHARMACIE DE PERIAZ ?

The revenue of GRANDE PHARMACIE DE PERIAZ in 2017 is 3.3 M€.

Is GRANDE PHARMACIE DE PERIAZ profitable?

Yes, GRANDE PHARMACIE DE PERIAZ generated a net profit of 278 k€ in 2024.

Where is the headquarters of GRANDE PHARMACIE DE PERIAZ ?

The headquarters of GRANDE PHARMACIE DE PERIAZ is located in ANNECY (74000), in the department Haute-Savoie.

Where to find the tax return of GRANDE PHARMACIE DE PERIAZ ?

The tax return of GRANDE PHARMACIE DE PERIAZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE DE PERIAZ operate?

GRANDE PHARMACIE DE PERIAZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.